Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
| Autor: | Ignatiadis, M. *, Litière, S., Rothe, F., Riethdorf, S., Proudhon, C., Fehm, T., Aalders, K., Forstbauer, H., Fasching, P.A., Brain, E., Vuylsteke, P., Guardiola, E., Lorenz, R., Pantel, K., Tryfonidis, K., Janni, W., Piccart, M., Sotiriou, C., Rack, B., Pierga, J.-Y. |
|---|---|
| Zdroj: | In Annals of Oncology August 2018 29(8):1777-1783 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|